Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2014 Publisher: The Boots Company PLC, 1 Thane Road West, Nottingham NG2 3AA Trading as: BCM
Pepti-Calm 525.6mg/30ml Oral Suspension or Almus Pepti-Calm Suspension Bismuth Subsalicylate 525.6mg/30ml.
| Pharmaceutical Form |
|---|
|
Oral suspension. Thick pink suspension. |
| Active ingredient | mg/30ml |
| Bismuth subsalicylate | 525.6 |
For excipients, see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Bismuth subsalicylate |
Bismuth subsalicylate is a derivative of salicylic acid, with anti-inflammatory and bactericidal action. Bismuth subsalicylate has weak antacid properties. Bismuth subsalicylate is used as an antacid and antidiarrheal, and to treat temporary discomfort of the stomach and gastrointestinal tract, such as nausea, heartburn, indigestion, upset stomach, and diarrhea. Bismuth subsalicylate may exert its antidiarrhoeal action not only by stimulating absorption of fluid and electrolytes across the intestinal wall but also when hydrolysed to salicylic acid, by inhibiting synthesis of a prostaglandin responsible for intestinal inflammation and hypermotility. |
| List of Excipients |
|---|
|
Maltitol liquid |
A 150ml, 180ml or 300ml white flint glass bottle with a roll on aluminium closure and expanded polyethylene liner.
The Boots Company PLC, 1 Thane Road West, Nottingham NG2 3AA
Trading as: BCM
PL 00014/0615
Date of first authorisation: 02 November 2000
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
